A new study has been published “highlighting the effectiveness of Lunit INSIGHT MMG in significantly reducing radiologists’ workload while enhancing cancer detection rates.”
Lunit INSIGHT MMG is “Lunit’s AI-powered solution for breast cancer detection,” and this research was undertaken in order to “assess its proficiency in early cancer detection within a breast cancer screening program.”
The study encompassed “over 22,621 mammograms from 8,825 women over a decade.” The researchers found that Lunit INSIGHT MMG had the “potential to reduce workflow by nearly 70% through a hybrid workflow scenario that categorizes mammograms into immediate review, further evaluation, or no action needed based on AI-assessed risk scores, alongside a 30.5% boost in cancer detection accuracy.”
In addition, “the study revealed that the AI system identified 51.72% of interval cancers, and 50% of missed cancers. Additionally, the study illustrated that using Lunit INSIGHT MMG as a second reader could potentially expedite the diagnosis by an average of nearly 30 months, compared to traditional screening methods.”
PR Newswire has the news release.
